Glazer Capital's Schedule 13G Filing for scPharmaceuticals Inc.

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G with the SEC, disclosing their ownership of 2,474,820 shares of common stock in scPharmaceuticals Inc., representing 4.64% of the outstanding shares. The filing indicates that Glazer Capital and Mr. Glazer may have previously owned more than 5% of the shares but have since reduced their holdings below this threshold. The filing is made under Rule 13d-1(c) and includes certifications that the shares were not acquired for the purpose of influencing the control of the issuer. The filing was signed by Paul J. Glazer, Managing Member of Glazer Capital, and by Paul J. Glazer individually.